ROYAL CARIBBEAN CRUISES LTD — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ROYAL CARIBBEAN CRUISES LTD filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $2.33B | Feb 22, 2019 |
| FY2018 | Sep 30, 2018 | $2.80B | Feb 22, 2019 |
| FY2018 | Jun 30, 2018 | $2.34B | Feb 22, 2019 |
| FY2018 | Mar 31, 2018 | $2.03B | Feb 22, 2019 |
| FY2018 | Dec 31, 2017 | $2.00B | Feb 22, 2019 |
| FY2018 | Sep 30, 2017 | $2.57B | Feb 22, 2019 |
| FY2018 | Jun 30, 2017 | $2.20B | Feb 22, 2019 |
| FY2018 | Mar 31, 2017 | $2.01B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $1.91B | Feb 21, 2018 |
| FY2017 | Sep 30, 2016 | $2.56B | Feb 21, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.94B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $16.48B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $13.90B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $8.84B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $1.53B | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | $34.14M | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | ($33.69M) | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $175.61M | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $2.03B | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $2.52B | Feb 26, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.27B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $2.88B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $1.70B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | ($2.16B) | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | ($5.26B) | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | ($1.37B) | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | ($1.35B) | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | ($1.64B) | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | ($1.44B) | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $273.14M | Feb 26, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.91B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $4.11B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $2.88B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | ($766.00M) | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | ($3.87B) | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | ($1.02B) | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | ($996.11M) | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | ($1.28B) | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | ($1.31B) | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $299.43M | Feb 26, 2021 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $41.62B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $37.07B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $35.13B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $33.78B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $32.26B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $32.47B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $30.32B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $27.70B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $22.36B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $22.31B | Feb 21, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $31.37B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $29.34B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $30.23B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $30.91B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $27.17B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $23.70B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $17.59B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $16.05B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $11.66B | Feb 22, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.04B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $7.56B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $4.72B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $2.87B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $5.09B | Feb 23, 2023 |
| FY2022 | Dec 31, 2020 | $8.76B | Feb 23, 2023 |
| FY2022 | Dec 31, 2019 | $12.16B | Feb 23, 2023 |
| FY2021 | Dec 31, 2018 | $11.11B | Mar 1, 2022 |
| FY2020 | Dec 31, 2017 | $10.70B | Feb 26, 2021 |
| FY2019 | Dec 31, 2016 | $9.12B | Feb 25, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 15 | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 11 | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | 6 | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | (8) | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | (20) | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | (6) | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | (6) | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | (7) | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | (6) | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | 1 | Feb 26, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 15 | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 10 | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | 6 | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | (8) | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | (20) | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | (6) | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | (6) | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | (7) | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | (6) | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | 1 | Feb 26, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $825.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $388.00M | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $497.00M | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $1.94B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $2.70B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $3.68B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $243.74M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $287.85M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $120.11M | Feb 22, 2019 |
| FY2018 | Dec 31, 2016 | $132.60M | Feb 22, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Dec 31, 2011 | $8.50B | Feb 29, 2012 |
| FY2011 | Dec 31, 2010 | $9.15B | Feb 29, 2012 |